The software significantly improves workflows for analysis, increasing efficiency and reducing costs REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k) clearance from […]
Tag: biotricity
Biotricity® Partners with Verizon to Develop EMS Solutions
Verizon to Integrate the Bioflux® Solution into their EMS and Launch to Existing and Future Customers REDWOOD CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon […]
Biotricity Shows Continued Growth through its Preliminary Year-End Guidance and Provides Calendar Second Quarter Update
REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today provided guidance on its financial results for the year ended March 31, 2020, announcing that it has experienced increases of approximately 260% […]
Biotricity Expands Board of Directors with New Appointment
Biotricity adds Steve Salmon to its Board of Directors, a Serial Entrepreneur and Successful Venture Capitalist with a track record in growing medical companies REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare […]
Biotricity’s Real-Time Monitoring Bioflux Device can Help Identify Life Threatening QT Prolongation in COVID-19 Patients
REDWOOD CITY, Calif., April 07, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Bioflux® units are designed for QT interval analysis, a section of the ECG, to identify serious risks like […]
Biotricity Posts Calendar Q4 Results that Show Continued Growth
REDWOOD CITY, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced calendar fourth quarter financial results for the three months which ended December 31, 2019. FOURTH QUARTER HIGHLIGHTS Revenues for the […]
Biotricity Files a 510(k) Application for its Advanced ECG Analysis Software
Company builds on its expansion into deeper data analysis and predictive analytics REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) application for US […]
Biotricity Prepares its Filing for a 510(k) Application for its Advanced ECG Analysis Software
REDWOOD CITY, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it is finalizing its FDA filing for its next generation, advanced ECG analysis software with an expectation to file […]
Biotricity Completes Development of its ECG Patch Platform
Company Prepares for FDA Filing of New Device REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed development of its ECG patch platform. An extension of the company’s […]
Biotricity Actively Pursues Holter Market with Bioflux Product Offering
REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will be actively pursuing the Holter market in addition to the MCT market with its Bioflux product offering, expanding its revenue […]